Competing autocrine pathways involving alternative neuropilin-1 ligands regulate chemotaxis of carcinoma cells

Cancer Research

Volumn 63, Issue 17, 2003, Pages 5230-5233

  Bachelder, Robin E ^a,c   Lipscomb, Elizabeth A ^a   Lin, Xuena ^a   Wendt, Melissa A ^a   Chadborn, Neil H ^b   Eickholt, Britta J ^b   Mercurio, Arthur M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; MESSENGER RNA; NERVE PROTEIN; NEUROPILIN 1; PLEXIN A1; SEMAPHORIN 3A; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; BREAST CARCINOMA; CARCINOMA CELL; CELL MIGRATION; CELL STRAIN 3T3; CELL STRAIN MCF 7; CHEMOTAXIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BREAST NEOPLASMS; CARCINOMA; CHEMOTAXIS; ENDOTHELIAL GROWTH FACTORS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIGANDS; LYMPHOKINES; NERVE TISSUE PROTEINS; NEUROPILIN-1; RECEPTORS, CELL SURFACE; RNA INTERFERENCE; RNA, MESSENGER; SEMAPHORIN-3A; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0141816865     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Soker, S., Takshima, S., Miao, H., Neufeld, G., and Klagsbrun, M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell, 92: 735-745, 1998.
2. Bachelder, R. E., Crago, A., Chung, J.. Wendt, M. A., Shaw, L. M., Robinson, G., and Mercurio, A. M. Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. Cancer Res., 61: 5736-5740, 2001.
3. He, Z., and Tessier-Lavigne, M. Neuropilin is a receptor for the axonal chemorepellent semaphorin III. Cell, 90: 739-751, 1997.
4. Kolodkin, A. L., Levengood, D. V., Rowe, E., Tai, Y., Giger, R. J., and Ginty, D. D. Neuropilin is a semaphorin III receptor. Cell, 90: 753-762, 1997.
5. Takahashi, T., Fournier, A., Nakamura, F., Wang, L., Murakami, Y., Kalb, R. G., Fujisawa, H., and Strittmatter, S. M. Plexin-neuropilin-1 complexes, form functional semaphorin-3A receptors. Cell, 99: 59-69, 1999.
6. Tamagnone, L., Artigiani, S., Chen, H., He, Z., Ming, G., Song, H., Chedotal, A., Winberg, M. L., Goodman, C. S., Poo, M., Tessier-Lavigne, M., and Comoglio, P. M. Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell, 99: 71-80, 1999.
7. Miao, H., Lee, P., Lin, H., Soker, S., and Klagsbrun, M. Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression. FASEB J., 14: 2532-2539, 2000.
8. Shaw, L. M., Rabinovitz, I., Wang, H., Toker, A., and Mercurio, A. M. Activation of phosphoinositide 3-OH kinase by the α6β4 integrin promotes carcinoma invasion. Cell, 91: 949-960, 1997.
9. Takahashi, T., and Strittmatter, S. M. Plexin A1 autoinhibition by the plexin SEMA domain. Neuron, 29: 429-439, 2001.
10. Cho, K. R., and Vogelstein, B. Genetic alterations in the adenoma-carcinoma sequence. Cancer (Phila.), 70: 1727-1731, 1992.
11. Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Nakamura, Y., White, R., Smits, A. M., and Bos, J. L. Genetic alterations during colorecial-tumor development. N. Engl. J. Med., 19: 525-532, 1988.
12. Herman, J. G. Hypermethylation of tumor suppressor genes in cancer. Semin. Cancer Biol., 9: 359-367, 1999.
13. Brown, L. F., Guidi, A. J., Schnitt, S. J., Van de Water, L., Iruela-Arispe, M. L., Yeo, T. K., Tognazzi, K., and Dvorak, H. F. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin. Cancer Res., 5: 1041-1056, 1999.
14. Salgen, P., Perhoniemi, V., Tykka, H., Maenpaa, H., and Joensuu, H. Serum VEGF levels in women with a benign breast tumor or breast cancer. Breast Cancer Res. Treat., 53: 161-166, 1999.
15. Miao, H., Soker, S., Feiner, L., Alonso, J. L., Raper, J. A., and Klagsbrun, M. Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165. J. Cell Biol., 146: 233-241, 1999.
16. Bagnard, D., Vaillant, C., Khuth, S., Dufay, N., Lohrum, M., Puschel, A. W., Belin, M., Bolz, J., and Thomasset, N. Semaphorin 3A-vascular endothelial growth factor-165 balance mediates migration and apoptosis of neural progenitor cells by the recruitment of shared receptor. J. Neurosci. 21: 3332-3341, 2001.
17. Bachelder, R. E., Ribick, M. J., Marchetti, A., Falcioni, R., Soddu, S., Davis, K. R., and Mercurio, A. M. p53 inhibits α6β4 integrin survival signaling by promoting the caspase 3-dependent cleavage of AKT/PKB. J. Cell Biol., 147: 1063-1072, 1999.